A number of other research firms also recently issued reports on GEVO. Zacks Investment Research downgraded Gevo from a “hold” rating to a “sell” rating in a research note on Wednesday, August 21st. HC Wainwright restated a “buy” rating and set a $10.00 price target on shares of Gevo in a research note on Thursday, August 15th.
NASDAQ:GEVO traded down $0.32 during mid-day trading on Tuesday, reaching $3.03. 315,080 shares of the stock were exchanged, compared to its average volume of 418,977. The company has a 50 day simple moving average of $3.00 and a 200-day simple moving average of $2.40. The stock has a market capitalization of $45.63 million, a P/E ratio of -0.58 and a beta of 2.60. Gevo has a 1 year low of $1.79 and a 1 year high of $4.97.
Gevo Company Profile
Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.
Featured Story: What does a neutral rating on stocks mean?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.